BioAtla, Inc. (BCAB) Misses Q2 EPS by 6c
BioAtla, Inc. (NASDAQ: BCAB) reported Q2 EPS of ($0.32), $0.06 worse than the analyst estimate of ($0.26).
For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.
BioAtla, Inc. (NASDAQ: BCAB) reported Q2 EPS of ($0.32), $0.06 worse than the analyst estimate of ($0.26).
For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.